Palestinian leader roundly rejects Trump peace plan

Palestinian President Mahmoud Abbas delivers a speech following the announcement by the US President Donald Trump of the Mideast peace plan. (Reuters)
Short Url
Updated 29 January 2020

Palestinian leader roundly rejects Trump peace plan

  • Mahmoud Abbas says Palestinians remain committed to ending the Israeli occupation
  • Calls for Palestinians to resist the plan through 'peaceful, popular means'

RAMALLAH: Palestinian President Mahmoud Abbas said “a thousand no's” Tuesday to the Mideast peace plan announced by President Donald Trump, which strongly favors Israel.
“After the nonsense that we heard today we say a thousand no's to the Deal of The Century," Abbas said at a press conference in the West Bank city of Ramallah, where the Western-backed Palestinian Authority is headquartered.
He said the Palestinians remain committed to ending the Israeli occupation and establishing a state with its capital in east Jerusalem.
“We will not kneel and we will not surrender,” Abbas said, adding that the Palestinians would resist the plan through “peaceful, popular means.”
The plan would create a Palestinian state in parts of the West Bank, but would allow Israel to annex nearly all of its settlements in the occupied territory. The plan would allow the Palestinians to establish a capital on the outskirts of east Jerusalem but would leave most of the city under Israeli control.
The Islamic militant group ruling Gaza rejected the "conspiracies" announced by the U.S. and Israel and said "all options are open" in responding to the Trump administration's plan.
“We are certain that our Palestinian people will not let these conspiracies pass. So, all options are open. The (Israeli) occupation and the U.S. administration will bear the responsibility for what they did," senior Hamas official Khalil al-Hayya said as he participated in one of several protests that broke out across the Hamas-ruled Gaza Strip.
Protesters burned tires and pictures of President Donald Trump and Israeli Prime Minister Benjamin Netanyahu.
Abbas held an emergency meeting with other Palestinian factions, including Hamas, to discuss a unified response to the plan. Abbas had rejected the deal before it was announced saying the U.S. was hopelessly biased toward Israel.
Jordan meanwhile warned against any Israeli "annexation of Palestinian lands" and reaffirmed its commitment to the creation of a Palestinian state along the 1967 lines, which would include all the West Bank and Israeli-annexed east Jerusalem.
Foreign Minister Ayman Safadi warned of “the dangerous consequences of unilateral Israeli measures, such as annexation of Palestinian lands.”
Jordan and Egypt are the only two Arab countries to have made peace with Israel.


Egypt sets virus vaccine target

Updated 42 min 39 sec ago

Egypt sets virus vaccine target

  • Volunteers will be closely monitored in order to take a second dose after 21 days

CAIRO: Assistant Health Minister and Coordinator of the Anti-COVID-19 Scientific Committee Ihab Kamal said that 842 people have volunteered in just one week to take part in Egypt’s coronavirus vaccine trials.

About 332 have been admitted in accordance with the health ministry’s requirements, which include being free from chronic disease.

Kamal said: “The number of volunteers until now is not low. We are working on raising the awareness of the citizens through various media platforms on the importance of the vaccine tests.” He added that the required number of volunteers is 6000.

He said the first two phases of the vaccine tests are complete and the third phase has begun. He added that volunteers are called for 21 days, pointing out that volunteers take a second dose in case they do not suffer any side effects. Kamal said the blood’s antibodies are measured throughout the year as part of the program.

Egyptian Minister of Health Hala Zayed announced on Thursday that she had launched the third and final phase of clinical trials on two vaccines developed by Egypt. She said the results of the two vaccine trials are positive so far.

Sources said that the Ministry of Health and the three centers taking part in the trials have received many applications. However, many of the applicants do not match the prerequisites, and therefore only 335 were accepted for the trials.

Zayed said in a press conference in Cairo that the current phase targets the participation of 6000 Egyptians. She said there are three places allocated for clinical trials.

Volunteers will be closely monitored in order to take a second dose after 21 days. After 45 days of the first dose, antibodies produced by the vaccine are measured to test their efficiency, Zayed said.

She said that national medical committees have been formed from civil and military bodies representing Egypt’s best medical experts.

She added that a committee will oversee conducting the clinical trials and that two vaccines out of seven have reached the third phase of clinical trials.

Zayed said that the first phase of the two vaccines included a test on a small group of 10 to 20 people with the aim of ensuring safety and also determining an appropriate dose. About 200 people took part in the second phase.

The third phase aimed included trials on 45,000 people from around the world, including 6,000 Egyptians.

The Ministry of Health and the company responsible for conducting the clinical trials explained the conditions that volunteers must follow to be eligible for tests.

They include an age bracket from 18 to 60 years old according to health condition. Registration must also be carried out using official documents. Volunteers must reside in Egypt or have valid residency documents during the trial period. Moreover, volunteers must sign an “informed consent” form prior to taking part in the trial.

There are a number of health conditions that prevent volunteers from taking part in the trials, including suffering from the symptoms of fever, dry cough, exhaustion and gonorrhea during the 14 days that precede the tests.